Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Trial of SP-8203 in Ischemic Stroke Patients Receiving rtPA
KCT0002120Phase 2Recruiting
- Sponsor
- Shinpoong Pharma
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of otaplimastat in ischemic stroke, sponsored by Shinpoong Pharma. Started Jun 2016; status: recruiting.
02
Drugs
otaplimastat
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on KCT0002120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002120.